Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
7.73 ^CNY	+3.07%		+6.33%	-13.63%

Apr. 25	Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	CI
Apr. 24	Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.

March 04, 2024 at 11:00 am EST

From February 5, 2024 to March 1, 2024, the company has repurchased 2,667,000 shares, representing 0.72% for CNY 15.1 million. With this, the company has completed the repurchase of 2,667,000 shares, representing 0.72% for CNY 15.1 million under the buyback announced on February 6, 2024.

Latest news about Boji Medical Technology Co.,Ltd.

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023	Apr. 24	CI
Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology	Apr. 08	MT
Boji Medical Technology's Unit Gets Nod to Market Erectile Dysfunction Tablets	Mar. 12	MT
Tranche Update on Boji Medical Technology Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	Mar. 04	CI
Boji Medical Technology Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 2,667,000 shares, representing 0.72% for CNY 15.10 million.	Feb. 29	CI
Boji Medical Technology Bags 107.7 Million Yuan Clinical Trial Assistance Deal; Shares Surge 20%	Feb. 19	MT
Boji Medical Technology Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	Feb. 05	CI
Boji Medical Technology Co., Ltd. authorizes a Buyback Plan.	Feb. 04	CI
Boji Medical Scores 54 Million Yuan Contract For Eye Drop Clinical Trial Research	Jan. 26	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors	23-08-03	CI
Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023	23-07-04	CI
Boji Medical Technology Co., Ltd. Proposes Cash Dividend for 2022	23-04-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Boji Medical Technology Gets Warning for Disclosure Breaches; Shares Jump 7%	23-02-28	MT
Boji Medical’s Chairman to Boost Stake to 39% After 84 Million Yuan Deal; Shares Rally 14%	23-02-15	MT
Boji Medical Technology Co., Ltd. announced that it expects to receive CNY 83.999999 million in funding	23-02-13	CI
Boji Medical Signs 55.5 Million Yuan Deal to Complete Trial of Therapeutic Drug	22-12-28	MT
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Boji Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022	22-05-26	CI
Boji CRO Approves Cash Dividend for the Year 2021	22-05-18	CI
Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-26	CI

Chart Boji Medical Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.

Sector

Biotechnology & Medical Research

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD.	-13.63%	405M
MODERNA, INC.	+25.71%	48.09B
LONZA GROUP AG	+46.90%	40.62B
IQVIA HOLDINGS INC.	-3.44%	40.43B
CELLTRION, INC.	-6.20%	28.36B
ICON PUBLIC LIMITED COMPANY	+9.22%	24.89B
ALNYLAM PHARMACEUTICALS, INC.	-20.41%	19.01B
MEDPACE HOLDINGS, INC.	+28.05%	12.09B
BIO-TECHNE CORPORATION	+0.23%	11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.19%	11.8B

Other Biotechnology & Medical Research